Sign Up to like & get
recommendations!
1
Published in 2022 at "European urology"
DOI: 10.1016/j.eururo.2022.03.010
Abstract: BACKGROUND For patients with neurogenic detrusor overactivity incontinence (NDOI), treatment with oral medications is often unsatisfactory. OBJECTIVE To assess the efficacy and safety of abobotulinumtoxinA (aboBoNT-A) for NDOI. DESIGN, SETTING, AND PARTICIPANTS Two randomized, double-blind…
read more here.
Keywords:
abobotulinumtoxina;
placebo;
overactivity;
detrusor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "International Journal of Neuroscience"
DOI: 10.1080/00207454.2017.1406935
Abstract: ABSTRACT Purpose/aim: AbobotulinumtoxinA (Dysport®, Ipsen Biopharmaceuticals, Inc., Basking Ridge, NJ, USA) is an acetylcholine release inhibitor and a neuromuscular blocking agent. The United States prescribing information for abobotulinumtoxinA previously indicated only one dilution for cervical…
read more here.
Keywords:
dilution;
500 dilution;
cervical dystonia;
abobotulinumtoxina ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Neurology"
DOI: 10.1111/ene.13800
Abstract: In patients with cervical dystonia, abobotulinumtoxinA solution for injection (ASI) has been shown to be similarly effective to freeze‐dried abobotulinumtoxinA in reducing Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total scores. In this secondary analysis,…
read more here.
Keywords:
abobotulinumtoxina;
quality life;
cervical dystonia;
patients cervical ... See more keywords